Genelux (GNLX) News Today $2.19 +0.27 (+14.06%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 19, 2024 | barrons.comGenelux Corp.July 10, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Insider Caroline Jewett Sells 4,961 SharesJuly 8, 2024 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Insider Sells $10,517.32 in StockGenelux Co. (NASDAQ:GNLX - Get Free Report) insider Caroline Jewett sold 4,961 shares of the business's stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $2.12, for a total value of $10,517.32. Following the sale, the insider now owns 16,174 shares in the company, valued at $34,288.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.June 9, 2024 | marketbeat.comWoodward Diversified Capital LLC Boosts Stock Holdings in Genelux Co. (NASDAQ:GNLX)Woodward Diversified Capital LLC increased its stake in Genelux Co. (NASDAQ:GNLX - Free Report) by 2,326.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,082,270 shares of the company's stock after buying an additionaJune 3, 2024 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Short Interest UpdateGenelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,440,000 shares, an increase of 5.2% from the April 30th total of 2,320,000 shares. Based on an average trading volume of 190,100 shares, the short-interest ratio is currently 12.8 days. Approximately 12.1% of the company's shares are short sold.May 31, 2024 | marketbeat.comGenelux (NASDAQ:GNLX) Price Target Cut to $25.00 by Analysts at BenchmarkBenchmark dropped their price objective on Genelux from $30.00 to $25.00 and set a "speculative buy" rating for the company in a research note on Friday.May 24, 2024 | msn.comWhy Genelux Corporation (GNLX) Shares Are Down 40%May 24, 2024 | globenewswire.comGenelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying WarrantsMay 23, 2024 | globenewswire.comGenelux Corporation Announces Proposed Public Offering of Common Stock and WarrantsMay 16, 2024 | finance.yahoo.comGenelux Corporation (GNLX)May 16, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 3,446 Shares of StockMay 15, 2024 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Sells $12,474.52 in StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 3,446 shares of the business's stock in a transaction on Monday, May 13th. The stock was sold at an average price of $3.62, for a total transaction of $12,474.52. Following the completion of the sale, the insider now owns 1,172,341 shares of the company's stock, valued at $4,243,874.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.May 13, 2024 | marketbeat.comGenelux's (GNLX) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $32.00 price objective on shares of Genelux in a research report on Monday.May 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for Genelux Corp on Strong Trial Progress and Solid FinancialsMay 10, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 6,025 Shares of StockMay 10, 2024 | investorplace.comGNLX Stock Earnings: Genelux Misses EPS for Q1 2024May 9, 2024 | marketbeat.comAladar Szalay Sells 6,025 Shares of Genelux Co. (NASDAQ:GNLX) StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 6,025 shares of the firm's stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $3.67, for a total transaction of $22,111.75. Following the completion of the sale, the insider now owns 1,189,706 shares in the company, valued at $4,366,221.02. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.May 9, 2024 | globenewswire.comGenelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesMay 5, 2024 | finance.yahoo.comGenelux Corporation's (NASDAQ:GNLX) market cap rose US$11m last week; individual investors who hold 54% profited and so did insidersMay 2, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Sells $20,809.75 in StockMay 2, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 33,061 Shares of StockApril 25, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 8,064 Shares of StockApril 20, 2024 | investing.comGenelux Corp insider sells shares worth over $250kApril 19, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 48,683 SharesApril 17, 2024 | msn.comGenelux (GNLX) Price Target Decreased by 22.96% to 26.52April 14, 2024 | marketbeat.comVanguard Group Inc. Buys 925,258 Shares of Genelux Co. (NASDAQ:GNLX)Vanguard Group Inc. boosted its stake in shares of Genelux Co. (NASDAQ:GNLX - Free Report) by 1,660.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 980,993 shares of the company's stock after buyinApril 4, 2024 | marketbeat.comResearch Analysts Set Expectations for Genelux Co.'s Q1 2024 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their Q1 2024 earnings estimates for shares of Genelux in a note issued to investors on Tuesday, April 2nd. HC Wainwright analyst E. Bodnar expects that the company will post earnings per share of ($0.26) for theApril 3, 2024 | marketbeat.comGenelux's (GNLX) "Speculative Buy" Rating Reiterated at BenchmarkBenchmark restated a "speculative buy" rating and set a $30.00 price objective on shares of Genelux in a research report on Wednesday.April 3, 2024 | marketbeat.comBrokers Set Expectations for Genelux Co.'s FY2028 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Genelux in a research report issued to clients and investors on Tuesday, April 2nd. HC Wainwright analyst E. Bodnar expects that the company will earn $0.82 per share for tApril 2, 2024 | marketbeat.comHC Wainwright Lowers Genelux (NASDAQ:GNLX) Price Target to $32.00HC Wainwright cut their price objective on Genelux from $35.00 to $32.00 and set a "buy" rating on the stock in a research report on Tuesday.April 2, 2024 | investorplace.comGNLX Stock Earnings: Genelux Misses EPS for Q4 2023April 1, 2024 | globenewswire.comGenelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 19, 2024 | seekingalpha.comAtossa climbs after cancer therapy updateMarch 15, 2024 | msn.comTD Cowen cuts Immuneering to market perform, cites Phase 1 dataMarch 15, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Expands By 30.3%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 29th, there was short interest totalling 1,590,000 shares, an increase of 30.3% from the February 14th total of 1,220,000 shares. Currently, 8.1% of the company's stock are short sold. Based on an average daily volume of 125,100 shares, the days-to-cover ratio is presently 12.7 days.March 10, 2024 | msn.comCytomX FY 2023 Earnings PreviewMarch 5, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 9.9%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 1,220,000 shares, an increase of 9.9% from the January 31st total of 1,110,000 shares. Currently, 6.2% of the company's shares are short sold. Based on an average trading volume of 132,200 shares, the short-interest ratio is presently 9.2 days.February 23, 2024 | benzinga.comGenelux Stock (NASDAQ:GNLX) Insider TradesFebruary 12, 2024 | msn.comG1 Therapeutics stock dives 36% post-market on P3 study updateFebruary 6, 2024 | msn.comGenelux Corp. Unveils Future-Oriented Corporate PresentationFebruary 3, 2024 | msn.comGenelux Corp. Estimates $23.2 Million in Year-End AssetsJanuary 23, 2024 | finance.yahoo.comHealthcare IT Leaders Adds Health Industry Veteran Mary Mirabelli to Board of DirectorsJanuary 2, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 11.1%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 889,700 shares, a growth of 11.1% from the November 30th total of 801,000 shares. Based on an average daily volume of 143,900 shares, the short-interest ratio is currently 6.2 days. Currently, 4.5% of the company's stock are sold short.December 24, 2023 | marketbeat.comAE Wealth Management LLC Has $4.77 Million Stock Position in Genelux Co. (NASDAQ:GNLX)AE Wealth Management LLC lifted its position in shares of Genelux Co. (NASDAQ:GNLX - Free Report) by 1,370.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 194,875 shares of the company's stock after buying an additional 181,618 sharesDecember 21, 2023 | benzinga.comGenelux Stock (NASDAQ:GNLX) Dividends: History, Yield and DatesDecember 15, 2023 | finance.yahoo.comInsider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX)December 14, 2023 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Director John Thomas Sells 9,000 SharesGenelux Co. (NASDAQ:GNLX - Get Free Report) Director John Thomas sold 9,000 shares of the business's stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $13.38, for a total value of $120,420.00. Following the sale, the director now owns 463,460 shares of the company's stock, valued at approximately $6,201,094.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.November 27, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of Genelux (GNLX) with Buy RecommendationNovember 27, 2023 | msn.comGenelux gets fast track status for Olvi-Vec in ovarian cancerNovember 27, 2023 | msn.comHC Wainwright starts Genelux at buy, cites Olvi-Vec potential Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! GNLX Media Mentions By Week GNLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNLX News Sentiment▼0.960.62▲Average Medical News Sentiment GNLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNLX Articles This Week▼31▲GNLX Articles Average Week Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Enanta Pharmaceuticals News Atea Pharmaceuticals News Verrica Pharmaceuticals News Alimera Sciences News Aquestive Therapeutics News Nature's Sunshine Products News Cartesian Therapeutics News ADC Therapeutics News Akebia Therapeutics News Omeros News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNLX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genelux Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genelux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.